1. 2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV. (September 2015) Authors: Nakatsumi, H.; Yuki, S.; Kawamoto, Y.; Muranaka, T.; Hatanaka, K.; Kato, T.; Meguro, T.; Nakamura, M.; Iwanaga, I.; Uebayashi, M.; Tateyama, M.; Eto, K.; Kudo, M.; Kato, S.; Okuda, H.; Sogabe, S.; Miyashita, K.; Sakata, Y.; Sakamoto, N.; Komatsu, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗